Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Deborah Bonazza is active.

Publication


Featured researches published by Deborah Bonazza.


International Journal of Endocrinology | 2015

Surgical and pathological changes after radiofrequency ablation of thyroid nodules

Chiara Dobrinja; Stella Bernardi; Bruno Fabris; Rita Eramo; Petra Makovac; Gabriele Bazzocchi; Lanfranco Piscopello; Enrica Barro; Nicolò de Manzini; Deborah Bonazza; Maurizio Pinamonti; Fabrizio Zanconati; Fulvio Stacul

Background. Radiofrequency ablation (RFA) has been recently advocated as an effective technique for the treatment of symptomatic benign thyroid nodules. It is not known to what extent it may affect any subsequent thyroid surgery and/or histological diagnosis. Materials and Methods. RFA was performed on 64 symptomatic Thy2 nodules (benign nodules) and 6 symptomatic Thy3 nodules (follicular lesions/follicular neoplasms). Two Thy3 nodules regrew after the procedure, and these patients accepted to undergo a total thyroidectomy. Here we present how RFA has affected the operation and the final pathological features of the surgically removed nodules. Results and Conclusions. RFA is effective for the treatment of Thy2 nodules, but it should not be recommended as first-line therapy for the treatment of Thy3 nodules (irrespective of their mutational status), as it delays surgery in case of malignancy. Moreover, it is unknown whether RFA might promote residual tumor progression or neoplastic progression of Thy3 lesions. Nevertheless, here we show for the first time that one session of RFA does not affect subsequent thyroid surgery and/or histological diagnosis.


Oncology Letters | 2017

Multicenter research into the quality of life of patients with advanced oropharyngeal carcinoma with long‑term survival associated with human papilloma virus

Giacomo Spinato; Marco Stellin; Giuseppe Azzarello; Deborah Bonazza; Fabrizio Zanconati; Doriano Politi; Salvatore Cocuzza; Paola Di Mauro; Simonetta Ausoni; Giovanni Tonoli; Giulio Costantini; Luigi Maiolino; Roberto Spinato; Maria Cristina Da Mosto; Lorena Baboci; Annarosa Del Mistro; Agostino Serra; Gian Carlo Tirelli

The treatment of advanced-stage oropharyngeal squamous cell carcinoma may utilize various modes, including combining surgery with chemoradiotherapy (CTRT), or primary CTRT followed by rescue surgery. In previous literature it has been revealed how patients treated with combined modes report a low quality of life (QoL) and severe consequences following surgery, radiotherapy and chemotherapy, in the short and in the long-term. The decrease in the QoL of patients treated with high-intensity multi-modal strategies highlights the necessity of modifying treatments, particularly for young HPV-positive patients, where an increased survival rate has already been reported. The modified treatment for HPV-positive tumors in the tonsils and at the base of the tongue is based on the deintensification of therapies aiming to reduce toxicity and thereby improve QoL in the long term, whilst still maintaining therapeutic effectiveness. The aim of the present study was to evaluate the QoL in patients with a long-term survival, who were treated with combined therapy for squamous cell tumors in the tonsils and at the base of the tongue, and to compare the results observed in HPV-positive and HPV-negative patients. According to statistical analysis, differences in the general QoL and in the single scales of the European Organization for the Research and Treatment of Cancer questionnaires were not correlated with the type of therapy selected for the particular patient. QoL considered the presence of HPV, the type of treatment, the subregion of the tonsils vs. the base of the tongue and the disease stage at the time of diagnosis, and was determined to be non-influential with regard to these specific variables.


Liver International | 2018

A simple in silico strategy identifies candidate biomarkers for the diagnosis of liver fibrosis in morbidly obese subjects

Pablo Giraudi; Sabrina Eliana Gambaro; Sofia Ornelas Arroyo; C.M. Chackelevicius; Michela Giuricin; Marta Silvestri; Daniele Macor; Lory Saveria Crocè; Deborah Bonazza; Giorgio Soardo; Nicolò de Manzini; Fabrizio Zanconati; Claudio Tiribelli; Silvia Palmisano; Natalia Rosso

Non‐alcoholic fatty liver disease (NAFLD) is a chronic liver disorder, tightly associated with obesity.


Molecules | 2018

Polymer-Mediated Delivery of siRNAs to Hepatocellular Carcinoma: Variables Affecting Specificity and Effectiveness

Rossella Farra; Francesco Musiani; Francesca Perrone; Maja Čemažar; Urška Kamenšek; Federica Tonon; Michela Abrami; Aleš Ručigaj; Mario Grassi; Gabriele Pozzato; Deborah Bonazza; Fabrizio Zanconati; Giancarlo Forte; Maguie El Boustani; Lucia Scarabel; Marica Garziera; Concetta Russo Spena; Lucia De Stefano; Barbara Salis; Giuseppe Toffoli; Flavio Rizzolio; Gabriele Grassi; Barbara Dapas

Despite the advances in anticancer therapies, their effectiveness for many human tumors is still far from being optimal. Significant improvements in treatment efficacy can come from the enhancement of drug specificity. This goal may be achieved by combining the use of therapeutic molecules with tumor specific effects and delivery carriers with tumor targeting ability. In this regard, nucleic acid-based drug (NABD) and particularly small interfering RNAs (siRNAs), are attractive molecules due to the possibility to be engineered to target specific tumor genes. On the other hand, polymeric-based delivery systems are emerging as versatile carriers to generate tumor-targeted delivery systems. Here we will focus on the most recent findings in the selection of siRNA/polymeric targeted delivery systems for hepatocellular carcinoma (HCC), a human tumor for which currently available therapeutic approaches are poorly effective. In addition, we will discuss the most attracting and, in our opinion, promising siRNA-polymer combinations for HCC in relation to the biological features of HCC tissue. Attention will be also put on the mathematical description of the mechanisms ruling siRNA-carrier delivery, this being an important aspect to improve effectiveness reducing the experimental work.


Medical Imaging 2018: Physics of Medical Imaging | 2018

Monochromatic breast CT: absorption and phase-retrieved images

Luca Brombal; Bruno Golosio; F Arfelli; Adriano Contillo; Pasquale Delogu; Sandro Donato; Giovanni Mettivier; P. Oliva; Luigi Rigon; Angelo Taibi; Giuliana Tromba; Fabrizio Zanconati; R Longo; Deborah Bonazza

A program devoted to perform the first in-vivo monochromatic breast computed tomography (BCT) is ongoing at the Elettra Synchrotron Facility. Since the synchrotron radiation provides high energy resolution and spatial coherence, phase-contrast (PhC) imaging techniques can be used. The latest high resolution BCT acquisitions of breast specimens, obtained with the propagation-based PhC approach, are herein presented as part of a wider framework, devoted to the optimization of acquisition and reconstruction parameters towards the clinical exam. Images are acquired with a state-of-the-art dead-time-free single-photon-counting CdTe detector with a 60 µm pixel size. The samples are imaged at 32 and 38 keV in continuous rotating mode, delivering 5-20 mGy of mean glandular dose (MGD). Contrast-to-noise ratio (CNR) and spatial resolution performances are evaluated for both absorption and phase-retrieved images considering tumor/adipose tissue interfaces. We discuss two different phase-retrieval approaches, showing that a remarkable CNR increase (from 0.5 to 3.6) can be obtained without a significant loss in spatial resolution. It is shown that, even if the non-phase-retrieved image has a poorer CNR, it is useful for evaluating the spiculation of a microcalcification: in this context, absorption and phase-retrieved images have to be regarded as complementary information. Furthermore, the first full volume acquisition of a mastectomy, with a 9 cm diameter and 3 cm height, is reported. This investigation on surgical specimens indicates that monochromatic BCT with synchrotron radiation in terms of CNR, spatial resolution, scan duration and scan volume is feasible.


Gynecological Endocrinology | 2018

Menstruation-related disseminated intravascular coagulation in an adenomyosis patient: case report and review of the literature

Alice Cernogoraz; Luigi Schiraldi; Deborah Bonazza; Giuseppe Ricci

Abstract Disseminated intravascular coagulation (DIC) is a high mortality coagulopathy that leads to simultaneous thrombotic and bleeding problems. It occurs as a complication in different disease as malignancies, obstetrical catastrophes, bacterial sepsis and traumas. We report on an extremely rare case of acute DIC in a patient with misdiagnosed adenomyosis and massive methrorragia which led to acute kidney failure. The patient was successfully treated with hysterectomy and blood product transfusions; however, a slight reduction of renal function persisted. We were able to confirm the cause-consequence link between adenomyosis and consumptive DIC since we saw the thrombi in the adenomyotic uterus from early hysterectomy specimen. Moreover, this is the first case, for the best of our knowledge, in which systemic consequences persist in an adenomyosis patient who developed a DIC. Early diagnose and treatment of acute DIC is essential for patient’s survival and to prevent severe complications: adenomyosis should be kept in mind as a possible cause of DIC when a patient shows up with massive bleeding.


Journal of Molecular Biomarkers & Diagnosis | 2017

ECOG or Karnofsky Performance Status to Assess Functionality in Glioblastoma Patients Among Different Observers

Cristiana Iacuzzo; Marina Troian; Laura Bonadio; Deborah Bonazza; Chiara Dobrinja; Gabriele Bellio; Serena Scomersi; Fabiola Giudici; Fabrizio Zanconati; Marina Bortul; Claudia Panciroli; Anna Estival; Giuseppe Lucente; Jose Maria Velarde; Roser García; Laia Vilà; Sira Domenech; Salvador Villà; Carmen Balana

Purpose: Glioblastoma (GB) patients usually have symptoms that affect their functional status, and medical staff, as well as the patients and their caregivers, might have different perceptions about it. The performance status is important to establish a patient’s survival prediction and treatment decisions. This study was aimed to explore whether health care providers, patients, and caregivers have a common perception of patients’ functional statuses and to investigate in further studies whether the functional scales used in oncology clinical practice are objective tools to evaluate brain tumour patients. Methods: GB patients treated at our Neuro-Oncology Unit were evaluated once using Eastern Cooperative Oncology Group Performance Status (ECOG) and Karnofsky Performance Status (KPS) by a medical oncologist (MO), an independent investigator (II), the patient and the patient’s main caregiver. Results: Fifty patients were enrolled. Concordance in KPS evaluation among the four observers was low (Fleiss’ Kappa=0.354; p<0.001) and moderate in ECOG one (Fleiss’ K=0.424; p<0.001). Pairing the observers, the concordance between the MO and II was strong (KPS Cohen’s Kappa=0.731; p<0.001, ECOG Cohen’s Kappa=0.741; p=0.001), whereas it was poor between the patient and MO (KPS Cohen’s Kappa=0.250; p=0.007. ECOG Cohen’s Kappa=0.241; p=0.009) and between the caregiver and MO (KPS Cohen’s Kappa=0.350; p<0.001. ECOG Cohen’s Kappa=0.346; p=0.000). Conclusion: Concordance among the observers was poor or moderate according to the functional scale used. Particularly, caregivers’ perception of the patients’ functional status was frequently worse than that of the professionals.


Journal of Molecular Biomarkers & Diagnosis | 2017

Evaluation of Sentinel Lymph Node Intraoperative Touch Imprint Cytology in Breast Cancer Surgery

Cristiana Iacuzzo; Marina Troian; Laura Bonadio; Deborah Bonazza; Chiara Dobrinja; Gabriele Bellio; Serena Scomersi; Fabiola Giudici; Fabrizio Zanconati; Marina Bortul

Background: One of the strongest prognostic factor for breast cancer is the regional lymph node status, which can be evaluated intraoperatively by sentinel lymph node biopsy. Many methods (e.g. frozen section, touch imprint cytology (TIC) and one-step nucleic-acid amplification) are available to detect metastatic cells in axillary lymph nodes. The aim of this study is to evaluate the feasibility of using TIC to detect metastatic cells in sentinel lymph nodes. Methods: This is a retrospective single center cohort analysis conducted on prospectively recorded data. The study included all patients admitted to the Department of General Surgery of Trieste University Hospital for invasive clinically node-negative breast cancer who underwent sentinel lymph node assessment by means of TIC. Results: Between January 2015 and December 2016, 343 patients (338 females and 5 males) underwent breast surgery and sentinel lymph node TIC. Patient’s median age was 66 (33-92) years. The sensitivity of TIC was 54% (95% C.I. 39% to 69%), whereas its specificity and accuracy were 99% (95% C.I. 98% to 100%) and 90%, respectively. The median time required to obtain the result was 20 (15-45) min. The overall cost per each TIC analysis was about 20.50€. Conclusion: Touch imprint cytology appears to be a fast, cost-effective and reliable technique to intraoperatively detect breast cancer lymph node metastasis.


Obesity Surgery | 2017

NOVEL BIOMARKERS FOR THE DIAGNOSIS OF LIVER FIBROSIS IN A HIGHLY RISK NAFLD COHORT in IFSO 2017 22(nd) World Congress

Silvia Palmisano; Pablo Giraudi; Marta Silvestri; Sabrina Eliana Gambaro; C.M. Chackelevicius; So Arroyo; Michela Giuricin; Daniele Macor; Saveria Croce; Deborah Bonazza; Giorgio Soardo; Nicolò de Manzini; Fabrizio Zanconati; Claudio Tiribelli; Natalia Rosso


Journal of Hepatology | 2016

Adipose Tissue-Liver Axis: Involvement of the TH17 Pathway in the Progression of Human NAFLD

C.M. Chackelevicius; Pablo Giraudi; Sabrina Eliana Gambaro; Silvia Palmisano; Michela Giuricin; N. de Manzini; Deborah Bonazza; Fabrizio Zanconati; Claudio Tiribelli; N. Rosso

Collaboration


Dive into the Deborah Bonazza's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

E. Ober

University of Trieste

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge